Back to Awarded Treatment Trials
Awarded Trial: 15T-008
Grant ID
15T-008
Illness
Schizophrenia
Primary Drug/Intervention
Sodium Butyrate
Primary Dosage
6.57 gms/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Cancelled
Investigator
Robert Smith
Sample Size
100
Duration of Study Period for Each Subject
91 days
Outcome Measurements
N/A
Results
Study was cancelled due to concerns that sodium butyrate had a distinct odor and would be difficult to use in a placebo-controlled trial.
Publication
N/A
Link
N/A
PI Name
Robert Smith
Degree
M.D., Ph.D.
Center
NYU-Psychiatry, NKI Neurochemistry
Institution
Nathan Kline Institute for Psychiatric Research
Address
140 Old Orangeburg, Bldg. 35, Rm N109E
City or Town
Orangeburg
State or Province
NY
Zip or Postal Code
10962
Country
USA
Email Address
rsmith@nki.rfmh.org